Clinical Trials

Colorado Springs Neurological Associates is one of the largest and longest-standing neuroscience medical practices in southern Colorado.  Our aim is to deliver the highest standard of neurological care – the same level of care we would want for ourselves or our loved ones.  The Center has a dedicated clinical research institute with experienced principal investigators and a full-time research staff.  Collectively, our investigators have vast experience conducting phase II through phase IV clinical trials in a broad range of neurologic diseases affecting adults and children.


 

Multiple Sclerosis Research:

1.    Title: PASS: A Prospective, Multicenter, Observational Post-Authorization Safety Study to Evaluate the Long Term Safety Profile of Lemtrada Treatment in Patients with Relapsing Forms of Multiple Sclerosis.
Sponsor: Genzyme
Principle Investigator: Laurence Adams, MD

2.    Title: Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
Sponsor: Adamas
Principle Investigator: Kimberly Wagner, MD

3.   Title: Passage: Long-term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on Gilenya (fingolimod) once daily.
Sponsor: Novartis
Principal Investigator: Aparna Komatineni, MD

ALS Research:

4.    Pennant Study:  A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis.
Sponsor: Mallinckrodt  
Principle Investigator: Julia Brinley, DO

5.   Title: Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Sponsor: ORION
Principle Investigator: Julia Brinley, DO

Epilepsy Research:

6. Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures/YKP3089C025
Sponsor: SK Life Science
Principle Investigator: Kimberly Wagner, MD

Orthostatic Hypotension Research:

7.    Title: Restore: Phase 4 Clinical Study of Northera “droxidopa” in Patients with Symptomatic Neurogenic Orthostatic Hypotension.
Sponsor: Lundbeck
Principle Investigator: Laurence Adams, MD

Adult Migraine Research:

8.   Title: ADVANCE study: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant For the Prevention of Migraine in Participants with Episodic Migraine (ADVANCE)”
Sponsor: Allergan
Principle Investigator: Gregory Ales, DO

Pediatric Migraine Research:

9.    Title: A Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of Onzetra Xsail (sumatriptan nasal powder) for the acute treatment of episodic migraine with or without aura in adolescents.
Sponsor: Avanir
Principal Investigator: Kimberly Wagner, MD

10.   Title: Duke Pediatric Migraine-and observational study of pediatric migraine, chronic migraine with or without aura
Sponsor: Duke University
Principle Investigator: Christen Kutz, PhD, PA-C

Alzheimer’s disease Research:

11.   Title: Generations 2: A randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s disease.
Sponsor: Novartis
Principal Investigator: Kimberly Wagner, MD

Research Staff